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Abstract
This study aimed to determine the postoperative fever index in the gynecologic oncology patient associated with
signiﬁcant infectious morbidity. A retrospective analysis was performed of 355 patients who underwent abdominal
surgery. Charts were reviewed to evaluate postoperative temperature and risk factors for infectious morbidity. Sta-
tistical analyses were performed as indicated by the data type, including the Student t test, Mann-Whitney U test,
c2 test, and 1-way analysis of variance. A value of P < .05 was considered signiﬁcant. There were 210 patients with
temperatures < 100.5F (group 1), 69 with a temperature  100.5F to < 101F (group 2), and 76 with a temperature
 101F (group 3). Demographic data were similar among groups. There were 285 diagnostic tests performed, with
51 test results indicative of infectious morbidity. Patients in group 3 underwent more testing and had more positive
test results compared with groups 1 and 2. The majority of diagnostic testing and positive test results (60%) were in
patients from group 3. Groups 1 and 2 were statistically similar in the number of positive test results and antibiotic
duration, demonstrating a lower risk of infectious morbidity compared with group 3. This study suggests that a
postoperative temperature of  101F appears to be a better predictor of signiﬁcant infectious morbidity compared
with the prior deﬁnition of a temperature  100.5F. Furthermore, this illustrates the need for the development of a
postoperative temperature evaluation protocol to avoid expensive evaluations and empiric treatment of benign causes
of postoperative fever.
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Clinicians are frequently faced with early postoperative fever in
surgical patients. This is especially true of gynecologic oncology
patients after abdominal surgery. Incidence of febrile morbidity in
gynecologic patients ranges from 5% to 75%, depending on the
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http://dx.doi.org/10.1016/j.cogc.2014.06.003infectious etiology is rarely the cause in this patient population.2
Over 90% of febrile morbidity is linked to noninfectious etiology.
Numerous studies support these ﬁndings and cite alternative causes
for early postoperative fever, including cytokines, interleukins, and
other causes of inﬂammation.2-5 Not only are these fevers often not
due to infectious causes, but also they often resolve spontaneously
without any intervention.6 Despite this, fevers encountered in the
early postoperative period are often evaluated with costly and
nonuniform approaches. It is not uncommon for such patients to
undergo multiple blood and urine cultures, urinalyses, chest ra-
diographs, computed tomography (CT) scans, and serum testing. In
addition to extensive evaluations, empiric antibiotics are frequently
started in conjunction with the evaluation, without a clear diagnosis
being identiﬁed.
The deﬁnition of postoperative fever has been a source of con-
troversy and ambiguity, often leading to more confusion than
clarity for physicians. Historically, the most frequent deﬁnition, as
described in Te Linde’s Operative Gynecology,7 is a “temperature ofClinical Ovarian and Other Gynecologic Cancer December 2013 - 1
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2 - Cli38C (100.4F) or greater on 2 occasions, at least 6 hours apart,
more than 24 hours after the surgical procedure.” This deﬁnition
has been supported in many publications on postoperative fever.8-14
Studies have recently indicated that this deﬁnition may be in error
and lead to unnecessary testing and concern. Lyon et al8 reviewed
257 postoperative gynecologic patients, publishing data supporting
that the commonly used threshold of 38C was not as discrimina-
tory as 38.3C (100.9F) in detecting postoperative morbidity.
Frequency of temperature greater than 38.4C (101.1F), as well as
the absolute degree of elevation, was suggested to relate to the
morbidity level. The deﬁnition of signiﬁcant fever used by Lyon
et al8 was at least 2 spikes of the temperature  38.4C in the
postoperative course. The suggested deﬁnition of postoperative fever
as  101F may improve discrimination between ill patients and
those with transient and inconsequential temperature elevations;
however, in the clinical setting, the seemingly more prevalent
concept of signiﬁcant postoperative fever includes a “diagnosis by
the attending physician, without apparent criteria,” as cited by
Shapiro et al15 in 1982 and revisited by Lyon et al8 in 2000.
This review sought to retrospectively evaluate and identify the
fever index and risk factors associated with infectious morbidity in
the postoperative abdominal surgical patient in the gynecologic
oncology population to better identify signiﬁcant postoperative
fever and potentially decrease the incidence of expensive evalua-
tions and empiric treatment of benign causes of postoperative
fever.
Patients and Methods
A retrospective chart review of 355 patients from the gynecologic
oncology service undergoing open abdominal surgery between 1999
and 2007 at the Medical University of South Carolina was per-
formed using the departmental billing database. Approval from the
institutional review board was obtained. Patients were cross-
referenced through an internal departmental database of all gyne-
cologic cases. Additional patients identiﬁed in the database were
added to the pool. Patients with postoperative fever deﬁned as
temperature  100.5F on at least 1 occasion were identiﬁed by
extensive review of the nursing records and vital sign documenta-
tion. Patients without this documented fever were considered as the
control population.
Baseline demographic data and medical history were collected.
Potential risk factors for infectious morbidity including preoper-
ative antibiotic use, blood loss, extent of tumor spread, intra-
operative antibiotic use, and incidence of intraoperative and
postoperative blood transfusion and duration of bladder cathe-
terization were noted. Wound contamination was deﬁned as the
contamination of the abdomen with bowel contents as noted in
the operative report. Onset of fever (hours postoperatively) and
maximum fever temperature were recorded. Fever evaluations
including urine and blood cultures, chest radiographs, and CT
scans were collected. Positive chest radiograph ﬁndings were
deﬁned as a diagnosis of pneumonia, whereas atelectasis and “low
lung volumes” were considered negative. Similarly, positive CT
scan ﬁndings were deﬁned as a diagnosis of pneumonia or abscess,
whereas pulmonary embolus and atelectasis diagnoses were deﬁned
as negative. Antibiotic use and duration were recorded. Prophy-
lactic antibiotic use was deﬁned as preoperative antibiotic usenical Ovarian and Other Gynecologic Cancer December 2013given before skin incision. Intraoperative antibiotic use was
deﬁned as the use of antibiotics during surgery, accounting for the
standard of care in the addition of antibiotics for concomitant
bowel surgery or for re-dosing based on blood loss and length of
surgery.
The data were separated into groups based on maximum post-
operative temperature, including temperature < 100.5F (deﬁned
as the control group, group 1), temperature  100.5F to < 101F
(group 2), and temperature  101F (group 3). Inclusion into
groups 2 and 3 required only 1 temperature in the aforementioned
range, occurring at any time in the postoperative period. Contin-
uous predictors were evaluated using the Student t test and Mann-
Whitney U test as appropriate. Categorical predictors were
compared using the c2 test or Somers D test for ordinal data. A
value of P < .05 was considered signiﬁcant.
Results
A total of 355 gynecologic oncology patients met inclusion
criteria; of those, 210 (59%) did not have a recorded temperature
greater than 100.5F and were considered the control in this
analysis. There were 145 patients (41%) who met the criteria for
febrile morbidity; 69 (48%) had a temperature between 100.5F
and < 101F, and 76 (52%) had a fever  101F. Demographic
data and medical comorbidities are shown in Table 1. The median
ages among groups 1 through 3 were 56.7, 56.2, and 50.3 years,
respectively (range, 16-89 years). The women in group 3 were
signiﬁcantly younger (P ¼ .006). The majority of women in all
groups were white, although groups 1 and 2 had a signiﬁcantly
higher percentage than group 3 (67.2% vs. 72.5% vs. 52.6%,
respectively; P ¼ .03). There were no signiﬁcant differences in
weight, body mass index, parity, or medical comorbidities among
the 3 groups.
Clinicopathologic characteristics including preoperative, intra-
operative, and postoperative factors were examined (Table 2). There
were no signiﬁcant differences in preoperative characteristics
among the groups, including preoperative laboratory values; pre-
operative hemoglobin, hematocrit, and white blood cell count;
preoperative length of hospital stay; or blood transfusion rates before
surgery. Prophylactic antibiotics were used in over 97% of all pa-
tients, with no difference between the 3 temperature groups.
Intraoperative factors were similar among groups, with no differ-
ences in operative time, estimated blood loss, wound contamination,
intraoperative antibiotic use, incidence of disseminated cancer,
choice of surgical incision, or intraoperative blood transfusion rate.
There were no differences in the rates of postoperative wound
infection, duration of urethral catheterization, use of nonsteroidal
anti-inﬂammatory drugs, or postoperative laboratory ﬁndings (he-
moglobin, hematocrit) among the groups. The median maximum
temperature was signiﬁcantly different between groups 2 and 3
(P < .0001), with medians of 100.7F (range, 100.5F-100.9F)
and 101.6F (range, 101F-103.7F), respectively. The median
onset of fever for both groups was after the ﬁrst 24 hours, with
groups 2 and 3 developing fevers at 33.5 and 31.8 hours post-
operatively, respectively. The rates of blood transfusion were
signiﬁcantly higher in groups 2 and 3 (40.6% and 42.1%) compared
with the control group (23.8%; P ¼ .002). Postoperative antibiotic
use was signiﬁcantly higher in group 3 compared with groups 1 and
Table 1 Demographic Data and Medical Comorbidities by Temperature Group
Variable
Group 1: Afebrile (n [ 210)
Group 2: ‡100.5F to <101F
(n [ 69) Group 3: ‡101F (n [ 76)
P
Median (Range)
Mean (SEM)
Median (Range)
Mean (SEM)
Median (Range)
Mean (SEM)
Age (years) 56 (16-89) 59 (16-83) 48 (23-84) .006
56.76 (1.007) 56.2 (1.86) 50.37 (1.75)
BMI 28.32 (18.2-54.3) 27.52 (17.5-50.2) 29.74 (17.5-68.3) .58
29.72 (0.56) 29.55 (0.88) 30.81 (1.12)
Parity 2 (0-6) 3 (0-5) 3 (0-3) .29
1.995 (0.079) 2.175 (0.15) 2.206 (0.14)
n (%) n (%) n (%)
Race
White 141 (67.2) 50 (72.5) 40 (52.6) .03
Black/Other 69 (32.8) 19 (27.5) 36 (47.3)
CHF History 5 (2.3) 0 (0) 0 (0) .09
Stroke History 4 (1.9) 1 (1.4) 1 (1.3) .93
Hypertension 88 (42) 23 (33.3) 30 (39.5) .43
Diabetes 31 (14.8) 7 (10.1) 16 (21.1) .18
Insulin Use 9 (4.3) 1 (1.4) 4 (5.3) .47
COPD 2 (1.0) 1 (1.4) 2 (2.6) .87
Bolded data represent statistically signiﬁcant values.
Abbreviations: BMI ¼ body mass index; CHF ¼ congestive heart failure; COPD ¼ chronic obstructive pulmonary disease; SEM ¼ standard error of the mean.
Caroline C. Billingsley et al2 (70% vs. 16.7% vs. 50.7%, respectively; P < .001). Analysis of
postoperative antibiotic use among individual groups found signif-
icant differences as well (group 1 vs. group 2, P ¼ .0001; group 1 vs.
group 3, P ¼ .0001; group 2 vs. group 3, P ¼ .03). Similarly, the
duration of postoperative antibiotic use (P ¼ .001), as well as the
length of postoperative hospital stay (P ¼ .0003), were signiﬁcantly
longer in group 3 compared with groups 1 and 2.
The number of evaluations for infectious etiologies in the post-
operative period was recorded. The numbers of urine cultures, chest
radiographs, CT scans, and blood cultures obtained were signiﬁ-
cantly higher in group 3 compared with groups 1 and 2 (P < .0001)
(Table 3). Of the 119 urine cultures obtained, only 20 (16.8%) had
positive results. More urine cultures were obtained with rising
temperatures (P < .0001); however, the percentage of cultures with
positive results per group was highest in group 1 (27.3%), followed
by group 2 (20.6%), and was the lowest in group 3 (11.1%). This
was not signiﬁcant (P ¼ .07) (Table 4).
Data were also collected on imaging evaluations including chest
radiographs and CT scans. Chest radiographs were ordered for 114
patients (32.1%) among all groups, but only 19 (16%) had positive
ﬁndings indicating an infectious cause. A signiﬁcantly higher
number of chest radiographs was obtained in groups 2 and 3
compared with group 1 (P < .0001) (see Table 3). Despite the
increasing number of radiographs ordered in groups 2 and 3, similar
rates of positive chest radiograph ﬁndings were present among the
respective temperature groups (15%, 15.6%, and 17.8%, respec-
tively; P ¼ .9) (see Table 4). CT scans were obtained on 12 patients
(9 with positive ﬁndings), all in group 3 with a fever  101F.
Blood cultures were collected for a total of 40 patients, with the
majority collected in group 3 (85%). The collection of bloodcultures was standardized to 2 blood cultures obtained from 2
separate sites for all patients. There were 3 blood cultures with
positive results, all in group 3 with a fever  101F. This represents
7.5% of all blood cultures obtained.
Clearly, the number of tests obtained was signiﬁcantly higher in
group 3 compared with groups 1 and 2 (165 vs. 52 vs. 68,
respectively; P < .0001) (Table 5). Whereas 39 patients in the
control group had a total of 52 tests obtained, 44 patients in group 2
underwent 68 tests, and 68 patients in group 3 had 165 tests per-
formed. The number of patients with positive test results per group
was signiﬁcantly higher in group 3 compared with groups 1 and 2
(P < .0001) (see Table 5). Patients with positive test results among
groups 1, 2, and 3 represented 4.2%, 16%, and 28.9%, respectively.
When comparing those patients with at least 1 positive test result,
there was no difference between groups 1 and 2 (P ¼ .8). However,
the number of patients with at least 1 positive test result in group 3
was signiﬁcantly higher compared individually with group 1 (P ¼
.0002) and with group 2 (P < .001). Overall, 19.6% of positive test
results were in the control group and 23.5% were from group 2,
whereas group 3, with a temperature> 101F, accounted for 56.9%
of the positive test results (P < .0001) (see Table 5).
Discussion
Postoperative fever is a common ﬁnding in the gynecologic
oncology patient after extensive open abdominal surgery. Although
the formal deﬁnition of postoperative fever requires 2 separate
documented temperature values, in many instances, it has become
reﬂex nature among providers to order costly, intensive, and invasive
tests to evaluate for possible etiologies of fever based on 1 temper-
ature value. The present data analysis required 1 temperature valueClinical Ovarian and Other Gynecologic Cancer December 2013 - 3
Table 2 Clinicopathologic Characteristics by Temperature Group
Operative Factor
Group 1: Afebrile
(n [ 210)
Group 2: ‡100.5F to <101F
(n [ 69)
Group 3: ‡101F
(n [ 76)
P
Median (Range)
Mean (SEM)
Median (Range)
Mean (SEM)
Median (Range)
Mean (SEM)
Fever Maximum Temperature (F) N/A 100.7 (100.5-100.9)
100.7 (0.01737)
101.6 (101-103.7)
101.7 (0.06914)
<.0001
Preoperative WBC Count (cells/mL) 7.18 (2.1-30)
7.63 (0.2063)
6.94 (2.5-11.4)
7.04 (0.2493)
7.09 (3.5-23)
7.57 (0.3612)
.33
Surgery Duration (min) 201 (45-580)
214.3
197 (74-591)
218.6
184.5 (50-428)
207.5
.76
Duration of Urethral Catheterization (h) 43.29 (5.6-347)
50.89
45.25 (5-94.5)
45.14
48.13 (17-314)
60.32
.10
Estimated Blood Loss (mL) 475 (0-4000)
630.1
425 (50-4600)
666.3
450 (50-4500)
635.0
.92
Onset of Fever (Hours Postoperatively) N/A 33.5 (0-125.3)
36.72 (2.701)
31.88 (0-230.8)
37.71 (4.381)
.85
Duration of Postoperative Antibiotic Use (h) 52 (10-336)
92.38 (14.62)
72 (6-288)
91.33 (13.50)
120 (10-504)
164.9 (17.65)
.0011
Length of Hospital Stay (d) 4.92 (1.8-24.4)
5.71 (0.22)
6.03 (2.2-29.7)
6.8 (0.49)
6.21 (2.9-22.9)
7.68 (0.51)
.0003
n (%) n (%) n (%)
Radical Hysterectomy 50 (23.8) 17 (24.6) 22 (28.9) .67
Wound Contamination, Intraoperative 1 (.5) 2 (2.9) 1 (1.3) .6
Wound Infection, Postoperative 3 (1.4) 2 (2.9) 5 (6.6) .07
Prophylactic Antibiotic Use 205 (97.6) 68 (98.6) 73 (96.1) .52
Intraoperative Antibiotic Use 60 (28.6) 16 (23.2) 23 (30.3) .57
Postoperative Antibiotic Use 35 (16.7) 35 (50.7) 53 (70) <.0001
Disseminated Cancer 53 (25.2) 22 (31.8) 22 (28.9) .56
Vertical Skin Incision 188 (89.5) 60 (87) 62 (81.6) .07
Postoperative pRBC Transfusion 50 (23.8) 28 (40.6) 32 (42.1) .002
NSAID Use 94 (44.8) 30 (43.5) 29 (38.2) .51
Bolded data represent statistically signiﬁcant values.
Abbreviations: N/A ¼ not applicable; NSAID ¼ nonsteroidal anti-inﬂammatory drug; pRBC ¼ packed red blood cells; WBC ¼ white blood cells.
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4 - Clifor inclusion into groups 2 and 3 to evaluate the risk of febrile
morbidity within a given temperature range. Additionally, it has
long been recognized that a large contributor to postoperative fever
is the inﬂammatory and immune response of the body to tissue
damage and destruction.2,5,6 Release of cytokines, interleukins, tu-
mor necrosis factors, and other endogenous pyrogens is a signiﬁcant
contributor to postoperative fever that can lead to expensive and
unnecessary evaluations searching for an infectious etiology that will
never be found.
Risk stratiﬁcation has been identiﬁed as a possible strategy for
reducing excessive evaluations and cost in the setting of earlyTable 3 Evaluation for Infectious Etiology by Temperature
Evaluation
Group 1: Afebrile
(n [ 210); n (%)
Grou
<101
Urine Culture 22 (10.5)
Chest Radiograph 26 (12.4)
Computed Tomography Scan 0 (0)
Blood Culture 4 (1.9)
Total Tests 52
Bolded data represent statistically signiﬁcant values.
nical Ovarian and Other Gynecologic Cancer December 2013postoperative fever. Stratifying patients into low-risk and high-risk
categories and standardizing evaluation and treatment based on
that stratiﬁcation has been found to decrease the use of empiric
antibiotics without compromising morbidity in low-risk gynecology
patients.2 Identifying risk factors associated with signiﬁcant post-
operative morbidity is essential to improve the care of gynecologic
oncology patients by avoiding unnecessary testing and treatment of
those without true pathology while promptly and adequately eval-
uating those patients with genuine etiology for fever. Traditionally, a
temperature of 38C (100.4F) or higher after the ﬁrst postoperative
24 hours usually prompts a “fever” workup, including history,p 2: ‡100.5F to
F (n [ 69); n (%)
Group 3: ‡101F
(n [ 76); n (%) P
34 (49.3) 63 (82.9) <.0001
32 (46.4) 56 (73.7) <.0001
0 (0) 12 (15.8) <.0001
2 (2.9) 34 (44.7) <.0001
68 165 Total: 285
Table 4 Results Indicative of Infectious Etiology of the Evaluations Performed by Temperature Group
Evaluation
Group 1: Afebrile
(n [ 210); n (%)
Group 2: ‡100.5F to
<101F (n [ 69); n (%)
Group 3: ‡101F
(n [ 76); n (%) P
Positive Urine Culture Results 6 (27.3) 7 (20.6) 7 (11.1) .068
Positive Chest Radiograph Findings 4 (15.4) 5 (15.6) 10 (17.9) .95
Positive Computed Tomography Scan Findings N/A N/A 9 (75) N/A
Positive Blood Culture Results 0 (0) 0 (0) 3 (8.8) .45
Abbreviation: N/A ¼ not applicable.
Caroline C. Billingsley et alphysical examination, and laboratory investigation. Unfortunately,
many times a history and physical examination may be ignored in the
reﬂexive ordering of diagnostic testing and laboratory evaluations.
The present evaluation conﬁrms data in the literature in regard to
management of postoperative “fever.” Reﬂexive laboratory evalua-
tion without regard to clinical evaluation appears to be alive and
well. In a study of 676 patients with gynecologic disease (benign
and malignant), 29% had a temperature of 100.4F or greater, and
72% of those had no infection diagnosed. There were 760 tests
performed, with only 17% yielding a positive result.1 In the present
study, 145 of 355 patients (41%) were noted to have a temperature
elevation over 100.4F, with only 76 (21%) having a temperature 
101F; 285 tests were ordered to evaluate possible infectious eti-
ologies (consisting of urine cultures, blood cultures, chest radio-
graphs, and CT scans), and only 51 (17.8%) were found to be
indicative of an infectious cause. Recognition of risk factors that
place a postoperative patient at risk for signiﬁcant infectious
morbidity is imperative for the appropriate testing and prompt
treatment to quickly ensue. Similarly, recognizing when testing is
not necessary for postoperative fever is just as important to avoid
costly and invasive evaluations for noninfectious causes of fever.
In a comparison of the rate of positive test results among groups,
there was no difference between groups 1 and 2. However, there
were considerably more positive test results in group 3 compared
with either group 1 (P ¼ .0002) or group 2 (P < .0011). Those in
group 3 with a temperature of  101F represent a different group
of postoperative infectious risk with a signiﬁcantly higher percentage
of positive test results compared with groups 1 and 2 (P < .0001)
(see Table 5). Despite a few differences in the evaluation and
management practices of groups 1 and 2, these 2 groups resemble
each other more so in regard to risk of febrile morbidity compared
with group 3. The signiﬁcance of a temperature over 101F in this
patient population indicates that the control group and group 2Table 5 Evaluations Performed and Results by Temperature Group
Variable
Group 1: Afebrile
(n [ 210); n (%)
No. of Patients Tested 39 (18.6)
Percentage of All Tests With Positive Results Per Group
(n ¼ 51)
10 (19.6)
No. of Patients With Positive Test Results (Per Group) 9 (4.2)
No. of Tests Obtained Per Group (of 285 Tests Ordered) 52 (18.2)
No. of Tests With Positive Results Per Group 10 (19.2)
Bolded data represent statistically signiﬁcant values.were statistically similar across almost all factors, whereas group 3
represented a separate risk category.
This study suggests that a postoperative temperature of  101F
appears to be the point at which there is a difference in the rate of
positive test results and febrile morbidity, indicating the need for
postoperative infectious evaluation in this population. With a very
low return of positive laboratory test results in patients with
temperature < 101F, there appears to be very little or no indica-
tion to obtain tests reﬂexively in this population unless indicated on
history and physical examination. The rates of positive chest
radiograph ﬁndings in groups 1 and 2 are the same (15.4% and
15.6%), and they are similar to that of group 3 (17.9%), suggesting
that in patients with temperature  101F, chest radiographs are
not a sensitive way to detect febrile morbidity. Given that there is
no difference among all groups in regard to positive urine culture
results and chest radiograph ﬁndings, additional information is
required to evaluate the differences in regard to symptomatic eval-
uation using urine cultures and chest radiographs in the post-
operative population compared with asymptomatic women. This
may be an area of future study.
This study highlights several deﬁcits in the management of
postoperative fever. There were no protocols or guidelines for
identifying what postoperative temperature is signiﬁcant or what
management should be prompted by it. The fact that several pa-
tients without a postoperative fever underwent laboratory testing
for unknown reasons and that some patients were administered
antibiotics other than prophylactic antibiotics at the time of sur-
gery, also for unknown reasons, illustrates this problem. Whereas
the majority of postoperative antibiotics were used in groups 2 and
3, there was no difference in the average duration of use of post-
operative antibiotics in groups 1 and 2. Groups 1 and 2 were
statistically similar in the number of positive test results and
antibiotic duration, demonstrating a lower risk of infectiousGroup 2: ‡100.5F to
<101F (n [ 69); n (%)
Group 3: ‡101F
(n [ 76); n (%) P
44 (63.8) 68 (89.5) <.0001
12 (23.5) 29 (56.9) <.0001
11 (16) 22 (28.9) <.0001
68 (23.9) 165 (57.9) <.0001
12 (17.6) 29 (17.6) .98
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6 - Climorbidity compared with group 3. It does appear that women
with postoperative fever of  101F were more actively evaluated
for an underlying infection, and although abnormal test results
were uncommon, the highest number of positive test results was
in this group. Therefore, it appears that a postoperative fever of
 101F is a better indicator of possible infection that needs
further evaluation.
Conclusion
These ﬁndings warrant the consideration of a new paradigm in
postoperative temperature evaluation, as well as the development
of a protocol for the management of postoperative temperature.
This protocol also should include a standard use of postoperative
antibiotics. The reason for the use of postoperative antibiotics in
afebrile patients is unknown and likely is provider preference. The
implementation of a protocol regarding evaluation of post-
operative temperature and the use of postoperative antibiotics is
required to reduce the use of antibiotics, to reduce the use of
diagnostic infectious testing, and to decrease medical costs. Pa-
tients with temperature < 101F should not undergo routine or
reﬂexively ordered testing unless signs or symptoms of an infec-
tious etiology are present on history and physical examination.
The present data add to the pool of knowledge of evidence-based
medicine in the postoperative open-abdominal surgical patient.
This retrospective study, as well as others in the literature, suggests
that a postoperative temperature of  101F appears to be a better
predictor of signiﬁcant infectious morbidity compared with the
prior deﬁnition of a temperature  100.5F. Furthermore, this
study illustrates the need for the implementation of a post-
operative temperature evaluation protocol to avoid expensivenical Ovarian and Other Gynecologic Cancer December 2013evaluations and empiric treatment of patients at low risk for in-
fectious morbidity.Disclosure
The authors have stated that they have no conﬂicts of interest.References
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